Six patients with seropositive rheumatoid arthritis who were not receiving gold or corticosteroids, were studied. Immunologically pure IgG was isolated from their serum by column chromatography on DEAE-cellulose. Each immunoglobulin preparation was labelled with radioiodine and injected back intravenously into the patient. Some preparations were also injected intraperitoneally in a batch ofmice (20 male; 20 female). The elimination of the isotope was followed by scintillation counting of serum samples (in man) and by whole radiation measurements (in mice). Biological half-lives were measured over 32 days in man and 14 days in the mouse.
Individual half-life values in man are shown in Table I . It would also be of interest to know whether your mice would show 'immune' elimination ofrheumatoid albumin. Your results are interesting but the interpretation of their immunological significance requires caution. DR. SWANNELL Our results show an increased catabolic rate for IgG in RA patients; this would certainly suggest an increased rate of metabolism. However, the increased rate of catabolism is not due to elevation of the serum IgG levels. Two of our healthy controls had higher IgG levels than the RA patients.
We are suggesting that a minor structural alteration of rheumatoid globulin makes the protein more antigenic in mice. It is unnecessary for such protein to bind with RF in order to produce pathological complexes. D R. W. W. B UCH A N A N (Glasgow) How would these mice handle another IgG antibody (say tetanus antibody). Would they regard rheumatoid albumen differently from normal? DR. SWANNELL Total haemolytic complement in serum and synovial fluid samples, which were paired whenever possible, was estimated by a method modified from Kabat and Mayer (1961) . A normal serum range was established in 42 healthy persons of 185 to 345 C'H50 units/ml (mean 265 ± 2 SD). The rank sum test was applied to the results for statistical evaluation (Table) . (2itnan and Sit'aj, 1963) , in articular cartilage, synovial fluid, and synovial membrane (McCarty and Hollander, 1961) , in hypophosphatasaemia (O'Duffy, 1970) , in haemachromatosis in similar locations (Atkins, Mclvor, Smith, Hamilton, and Williams, 1970) as well as in the intervertebral discs in that condition and in hyperparathyroidism, and in ochronotic synovial membrane (Bywaters, unpublished data). We now record calcium pyrophosphate crystal deposition in synovial membranes of three out of 43 consecutive rheumatoid arthritis patients removed during arthroplasties, and in two more since then. Each of the three patients had had chronic progressive symmetrical erosive seropositive polyarthritis for over 12 years and each had shown the changes expected of rheumatoid arthritis in the tissues removed at arthroplasty. What was not expected was the presence of pyrophosphate. In one case, this was detected only microscopically: positively birefringent crystals were embedded in a basophil matrix and enclosed in giant cells, multinucleate and with eosinophil cytoplasm. In the second case, these deposits were numerous and associated with hydroxyapatite deposition in the synovial membrane. In the third case (who had had rheumatoid arthritis for 40 years, since the age of 30 with erosions, nodules, a raised erythrocyte sedimentation rate, and a positive latex test) arthroplasty showed an eroded joint covered with calcific deposits, visible grossly and also radiologically and microscopically. She had had neither steroid, gold, nor local cortisone injections. Serum calcium, phosphorus, and phosphatase were normal. Such crystal deposits occurred mainly in avascular villi and in joints with a considerable accumulation of necrotic bone fragments.
The wide spectrum of diseases with calcium pyrophosphate crystal deposition seems to imply an innate tendency for this to occur in the synovial milieu.
While 
